**Core Concept**
Dysthyroid eye disease, also known as Grave's ophthalmopathy, is a complex autoimmune inflammatory condition associated with Graves' disease. It involves orbital soft tissue expansion and potentially sight-threatening complications.

**Why the Correct Answer is Right**
Grave's ophthalmopathy results from an autoimmune response to the thyroid-stimulating hormone receptor (TSH-R) on the surface of orbital fibroblasts, leading to the activation of these cells and subsequent production of glycosaminoglycans, cytokines, and chemokines. This process causes inflammation, edema, and fibrosis in the orbital tissues, resulting in proptosis, eyelid retraction, and potential vision loss. The condition is often bilateral and can be exacerbated by radiation therapy to the head and neck region.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because dysthyroid eye disease is not primarily caused by a bacterial infection. While infection can exacerbate the condition, it is not a primary etiological factor.
**Option B:** This option is incorrect because dysthyroid eye disease is not typically treated with antibiotics. Antibiotics may be used to treat secondary infections, but they do not address the underlying autoimmune process.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that the severity of dysthyroid eye disease does not correlate with the severity of hyperthyroidism. Patients with mild hyperthyroidism can develop severe ophthalmopathy, and vice versa.

**Correct Answer: C.**